Diabetes UK   Report issue

Foundation Phase 2 Phase 3 Phase 4
Founded: London United Kingdom (1934)

Organization Overview

First Clinical Trial
1997
NCT00327418
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Diabetes UK

Active Ingredients

Drugs in Phase 4 Trials (1)

atorvastatin (lipitor) (2 trials)

Drugs in Phase 3 Trials (1)

quinapril (accupril) (1 trial)

Drugs in Phase 2 Trials (2)

cannabis (1 trial)

insulin human (humulin) (1 trial)

Drugs in Other Trials (4)

acipimox (1 trial)

beetroot juice (1 trial)

liraglutide (victoza) (1 trial)

rutin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina, Unstable (Phase 4)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 3)

Diabetic Neuropathies (Phase 2)

Pain (Phase 2)

Peripheral Nervous System Diseases (Phase 2)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 8